Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Kintor Pharmaceutical Ltd ( (HK:9939) ) is now available.
Kintor Pharmaceutical Ltd has announced a board meeting scheduled for March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. This meeting is pivotal for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming year.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd is a company in the pharmaceutical industry, focusing on the development and commercialization of innovative therapies. It is incorporated in the Cayman Islands and operates with a market focus on advancing treatments for unmet medical needs.
YTD Price Performance: 16.49%
Average Trading Volume: 1,263,921
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$497.5M
For an in-depth examination of 9939 stock, go to TipRanks’ Stock Analysis page.